Tissue Repair Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRP.AX research report →
Price Chart
About the company
Tissue Repair Ltd (TRP. AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures.
- CEO
- Tony Charara
- IPO
- 2021
- Employees
- 5
- HQ
- Chatswood, NSW, AU
Get TickerSpark's AI analysis on TRP.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.14M
- P/E
- -1.34
- PEG
- -0.09
- P/S
- 2.25
- P/B
- 0.43
- EV/EBITDA
- 0.66
- Div Yield
- 0.00%
- Gross Margin
- 86.61%
- Op Margin
- -215.26%
- Net Margin
- -168.53%
- ROE
- -29.91%
- ROIC
- -17.60%
Latest fiscal year · YoY change
- Revenue
- $2.63M+1629.7%
- Gross Profit
- $2.63M+1649.6%
- Op Income
- $-4,721,499
- Net Income
- $-4,238,501-2.4%
- EPS
- $-0.07-2.5%
- OCF Growth
- +25.3%
- FCF Growth
- +16.8%
- 52W High
- $0.48
- 52W Low
- $0.06
- 50D MA
- $0.10
- 200D MA
- $0.19
- Beta
- 0.22
- RSI (14)
- 44
- Avg Volume
- 72.84K
No earnings-call transcripts are available for TRP.AX yet.
- Free Float
- 91.9%
- Shares Outstanding
- 60.46M
- Float Shares
- 55.57M
Our TRP.AX coverage
Recent articles, reports, and earnings notes.
No research on TRP.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRP.AX report →